Fennec Pharmaceuticals (FENC) Other Working Capital Changes (2010 - 2025)
Fennec Pharmaceuticals' (FENC) quarterly Other Working Capital Changes came in at $1.4 million in Q4 2025, up 296.8% YoY from $340727.8 in Q4 2024, and up 360.0% on a QoQ basis from -$520000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) Other Working Capital Changes (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 15 years of Other Working Capital Changes data on file, last reported at $1.4 million in Q4 2025.
- Quarterly Other Working Capital Changes fell 100.01% year-over-year to -$2000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was -$439000.0 (changed N/A YoY) and the FY2024 annual result came in at $24.8 million, changed N/A from the prior year.
- Other Working Capital Changes grew to -$2000.0 in Q1 2025, from -$437000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $25.2 million in Q1 2024 to a low of -$437000.0 in Q3 2024.
- A 4-year average of $29187.5 and a median of $1000.0 in 2021 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes sank 200.0% — and 2025, when it jumped 303.76%.
- Tracing FENC's Other Working Capital Changes over 2 years: stood at -$437000.0 in 2024, then surged by 99.54% to -$2000.0 in 2025.
- The last three Other Working Capital Changes figures came in at -$2000.0 (Q1 2025), -$437000.0 (Q3 2024), and $25.2 million (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.35 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | -520,000.00 |
| Sep 30, 2025 | -520,000.00 |
| Sep 30, 2025 | -520,000.00 |
| Jun 30, 2025 | -102,000.00 |
| Jun 30, 2025 | -102,000.00 |
| Jun 30, 2025 | -102,000.00 |
| Mar 31, 2025 | 537,000.00 |
| Mar 31, 2025 | 537,000.00 |
| Mar 31, 2025 | 537,000.00 |
| Dec 31, 2024 | -687,000.00 |
| Dec 31, 2024 | -687,000.00 |
| Dec 31, 2024 | -687,000.00 |
| Sep 30, 2024 | -364,000.00 |
| Sep 30, 2024 | -364,000.00 |
| Sep 30, 2024 | -364,000.00 |
| Jun 30, 2024 | 122,000.00 |
| Jun 30, 2024 | 122,000.00 |